iifl-logo

News Overview

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Download App
image

Record date is 24 March 2022

image

Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to market Colestipol hydrochloride tablets.

image

On 9 April 2022

image

WAMIL’s facilities at Telangana have installed a capacity of 17,729 MTPA of Spunlace with estimated revenue of Rs370 crore per annum at around full capacity utilization.

image

Brightcom Group Ltd has lost 35.8% over last one month compared to 3.21% gain in S&P BSE IT Sector index and 4.14% drop in the SENSEX

image

On 23 March 2022

image

On 21 March 2022

image

ISMT announced that the company has remitted the full and final settlement amount, towards the outstanding debt of the Company, to the respective Lenders/ Authorized Dealers. Powered by Capital Market – Live News

Download App
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.